申请人:Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
公开号:US20150166572A1
公开(公告)日:2015-06-18
The present invention relates to novel halogenated benzoxazines, methods for their production, their use for the diagnosis of diseases and their use for the production of medicaments for the diagnosis of diseases, preferably dementia diseases and in particular the Alzheimer's disease, in humans and/or animals.
本发明涉及新型卤代苯并噁嗪,其生产方法,其用于疾病诊断的用途,以及其用于生产用于疾病诊断的药物的用途,优选是用于人类和/或动物的痴呆症疾病,特别是阿尔茨海默病。